Literature DB >> 3510233

Causes of sudden death in competitive athletes.

B J Maron, S E Epstein, W C Roberts.   

Abstract

Cardiovascular diseases responsible for sudden unexpected death in highly conditioned athletes are largely related to the age of the patient. In most young competitive athletes (less than 35 years of age) sudden death is due to congenital cardiovascular disease. Hypertrophic cardiomyopathy appears to be the most common cause of such deaths, accounting for about half of the sudden deaths in young athletes. Other cardiovascular abnormalities that appear to be less frequent but important causes of sudden death in young athletes include congenital coronary artery anomalies, ruptured aorta (due to cystic medial necrosis), idiopathic left ventricular hypertrophy and coronary artery atherosclerosis. Diseases that appear to be very uncommon causes of sudden death include myocarditis, mitral valve prolapse, aortic valve stenosis and sarcoidosis. Cardiovascular disease in young athletes is usually unsuspected during life, and most athletes who die suddenly have experienced no cardiac symptoms. In only about 25% of those competitive athletes who die suddenly is underlying cardiovascular disease detected or suspected before participation and rarely is the correct clinical diagnosis made. In contrast, in older athletes (greater than or equal to 35 years of age) sudden death is usually due to coronary artery disease, and rarely results from congenital heart disease.

Entities:  

Mesh:

Year:  1986        PMID: 3510233     DOI: 10.1016/s0735-1097(86)80283-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  85 in total

1.  Commotio cordis: an underappreciated cause of sudden death in athletes.

Authors:  F Lateef
Journal:  Sports Med       Date:  2000-10       Impact factor: 11.136

Review 2.  The pre-participation examination for leisure time physical activity: general medical and cardiological issues.

Authors:  Herbert Löllgen; Dieter Leyk; Jochen Hansel
Journal:  Dtsch Arztebl Int       Date:  2010-10-22       Impact factor: 5.594

3.  A low prevalence of MYH7/MYBPC3 mutations among familial hypertrophic cardiomyopathy patients in India.

Authors:  Murali D Bashyam; Guroji Purushotham; Ajay K Chaudhary; Katika Madhumohan Rao; Vishal Acharya; Tabrez A Mohammad; Hampapathalu A Nagarajaram; Vuppaladadhiam Hariram; Calambur Narasimhan
Journal:  Mol Cell Biochem       Date:  2011-09-29       Impact factor: 3.396

4.  Electrocardiographic Characterization of Cardiac Hypertrophy in Mice that Overexpress the ErbB2 Receptor Tyrosine Kinase.

Authors:  Polina Sysa-Shah; Lars L Sørensen; M Roselle Abraham; Kathleen L Gabrielson
Journal:  Comp Med       Date:  2015-08       Impact factor: 0.982

5.  Expression of a missense mutation in the messenger RNA for beta-myosin heavy chain in myocardial tissue in hypertrophic cardiomyopathy.

Authors:  M B Perryman; Q T Yu; A J Marian; A Mares; G Czernuszewicz; J Ifegwu; R Hill; R Roberts
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

6.  Physiological upper limits of left ventricular dimensions in highly trained junior tennis players.

Authors:  Sandeep Basavarajaiah; Mathew Wilson; Reza Naghavi; Gregory Whyte; Mike Turner; Sanjay Sharma
Journal:  Br J Sports Med       Date:  2007-11       Impact factor: 13.800

7.  William Clifford Roberts, MD: an interview by W. Bruce Fye, MD.

Authors:  William C Roberts; W Bruce Fye
Journal:  Proc (Bayl Univ Med Cent)       Date:  2007-07

8.  Medical malpractice and the sports medicine clinician.

Authors:  Steven M Kane; Richard A White
Journal:  Clin Orthop Relat Res       Date:  2008-11-07       Impact factor: 4.176

9.  Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy.

Authors:  O Roopnarine; L A Leinwand
Journal:  Biophys J       Date:  1998-12       Impact factor: 4.033

Review 10.  Sudden Cardiac Death in the Young.

Authors:  Michael Ackerman; Dianne L Atkins; John K Triedman
Journal:  Circulation       Date:  2016-03-08       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.